Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer Immunotherapy https://www.biorxiv.org/content/10.1101/2023.08.09.552650v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.